ICON plc, a global provider of pharmaceutical, biotechnology and medical devices, , has announced its financial results for the first quarter 2015.
The results shows Revenues Rise to $388.2 Million at +11.0% and EPS was $0.9 up by +57.9%.
View the full earnings release here.